Publication | Open Access

Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

Gastro-oesophageal Junction CancerEsophageal CancerGastrointestinal OncologyMedicineGastroenterologySurgeryUpper Gastrointestinal SurgeryAdvanced GastricCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentCancer Research